m+Medelevator.RU
← Поиск публикаций
Perfusion · 2026

Hemodynamic monitoring during veno-venous extracorporeal membrane oxygenation: A scoping review.

СтатьяScoping ReviewНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Lorusso Roberto, De Piero Maria Elena, Mariani Silvia, Ravaux Justine M, Nardelli Pasquale, Jacobs Jeffrey P, Guarracino Fabio, Patroniti Nicoló, van Bussel Bas C T, van der Horst Iwan C C, Taccone Fabio Silvio, Heinsar Silver, Shekar Kiran, Yamashita Michael H, Obonyo Nchafatso G, Ciullo Anna L, Riera Jordi, Dalton Heidi, Wang Anson, Zaaqoq Akram M, MacLaren Graeme, Ramanathan Kollengode, Suen Jacky Y, Li Bassi Gianluigi, Sato Kei, Fraser John F, Peek Giles J, Arora Rakesh C, COVID-19, Critical Care Consortium (CCCC) Cardio/ECMOCard

Аннотация

BackgroundIn adult patients receiving veno-venous Extracorporeal Membrane Oxygenation (VV ECMO), cardiovascular performance plays a critical role in determining oxygen delivery, organ perfusion and safe titration of extracorporeal support. Despite the increasing VV ECMO use, contemporary guidance on hemodynamic monitoring remains limited and largely experience-based. This scoping review aimed to map available basic and advanced monitoring approaches and to identify current evidence gaps.MethodsPubMed, EMBASE, and Cochrane CENTRAL were searched from inception until September 2025, along with reference lists of relevant articles. We included studies of any design reporting techniques, targets, or protocols for hemodynamic monitoring during VV ECMO.ResultsOf 465 records screened, 106 met inclusion criteria. No protocolized, evidence-based hemodynamic monitoring protocol specific to VV ECMO was identified. The available evidence was heterogeneous and mostly derived from physiologic studies or single-center observational cohorts. Findings were narratively synthesized across three domains: basic bedside monitoring, diagnostic/prognostic tools and advanced assessment of cardiopulmonary interaction. Across studies, no monitoring strategy consistently reduced time-to-wean or mortality. Observational data suggested that care bundles and multidisciplinary approaches may reduce complications. However, the risk of bias limits causal inference.ConclusionsDespite the complex interaction between native cardiovascular function and extracorporeal circulation, VV ECMO lacks consensus on evidence-based hemodynamic monitoring pathways. A pragmatic core monitoring bundle with tiered triggers for escalation is necessary. Future priorities include implementation models based on multidisciplinary teams, specific training, standardized bundles, and multicenter studies aimed to define right ventricular-centered targets to improve safety and clinical decision-making.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты